Skip to main content
Veterinary Medicines

RONAXAN 20 MG TABLETS FOR DOGS AND CATS

Authorised
  • Doxycycline hyclate

Product identification

Medicine name:
RONAXAN, 20mg, Tableta
RONAXAN 20 MG TABLETS FOR DOGS AND CATS
Active substance:
  • Doxycycline hyclate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Doxycycline hyclate
    23.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA02
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Available in:
  • Czechia
Package description:
  • Cardboard box containing 2 blisters of 10 tablets
  • Cardboard box containing 100 blisters of 10 tablets
  • Cardboard box containing 50 blisters of 10 tablets
  • Cardboard box containing 10 blisters of 10 tablets
  • Cardboard box containing 5 blisters of 10 tablets
  • Cardboard box containing 1 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/526/94-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Combined File of all Documents

English (PDF)
Published on: 19/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."